Published online June 4, 2007
doi:10.1084/jem.20062694
The Journal of Experimental Medicine, Vol. 204, No. 6, 1475-1485
The Rockefeller University Press, 0022-1007 $30.00
© 2007 Reiley et al.
Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responses
William W. Reiley1,
Wei Jin1,
Andrew Joon Lee1,
Ato Wright1,
Xuefeng Wu1,
Eric F. Tewalt1,
Timothy O. Leonard2,
Christopher C. Norbury1,
Leo Fitzpatrick3,
Minying Zhang1, and
Shao-Cong Sun1
1 Department of Microbiology and Immunology, 2 Department of Pathology, and 3 Department of Surgery, Pennsylvania State University College of Medicine, Hershey, PA 17033
CORRESPONDENCE Shao-Cong Sun: sxs70{at}psu.edu
The deubiquitinating enzyme CYLD has recently been implicated in the regulation of signal transduction, but its physiological function and mechanism of action are still elusive. In this study, we show that CYLD plays a pivotal role in regulating T cell activation and homeostasis. T cells derived from Cyld knockout mice display a hyperresponsive phenotype and mediate the spontaneous development of intestinal inflammation. Interestingly, CYLD targets a ubiquitin-dependent kinase, transforming growth factor–ß-activated kinase 1 (Tak1), and inhibits its ubiquitination and autoactivation. Cyld-deficient T cells exhibit constitutively active Tak1 and its downstream kinases c-Jun N-terminal kinase and I
B kinase ß. These results emphasize a critical role for CYLD in preventing spontaneous activation of the Tak1 axis of T cell signaling and, thereby, maintaining normal T cell function.
Abbreviations used: DUB, deubiquitinating enzyme; EMSA, electrophoresis mobility shift assay; ERK, extracellular-regulated kinase; GST, glutathione S-transferase; IB, immunoblotting; IBD, inflammatory bowel disease; IKK, I
B kinase; IP, immunoprecipitation; JNK, c-Jun N-terminal kinase; Tak1, TGF-ß–activated kinase 1.
W. W. Reiley and W. Jin contributed equally to this paper.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Duwel, M., Welteke, V., Oeckinghaus, A., Baens, M., Kloo, B., Ferch, U., Darnay, B. G., Ruland, J., Marynen, P., Krappmann, D.
(2009). A20 Negatively Regulates T Cell Receptor Signaling to NF-{kappa}B by Cleaving Malt1 Ubiquitin Chains. J. Immunol.
182: 7718-7728
[Abstract]
[Full Text]
-
Omori, E., Morioka, S., Matsumoto, K., Ninomiya-Tsuji, J.
(2008). TAK1 Regulates Reactive Oxygen Species and Cell Death in Keratinocytes, Which Is Essential for Skin Integrity. J. Biol. Chem.
283: 26161-26168
[Abstract]
[Full Text]
-
Zhang, M., Wu, X., Lee, A. J., Jin, W., Chang, M., Wright, A., Imaizumi, T., Sun, S.-C.
(2008). Regulation of I{kappa}B Kinase-related Kinases and Antiviral Responses by Tumor Suppressor CYLD. J. Biol. Chem.
283: 18621-18626
[Abstract]
[Full Text]
-
Koga, T., Lim, J. H., Jono, H., Ha, U. H., Xu, H., Ishinaga, H., Morino, S., Xu, X., Yan, C., Kai, H., Li, J.-D.
(2008). Tumor Suppressor Cylindromatosis Acts as a Negative Regulator for Streptococcus pneumoniae-induced NFAT Signaling. J. Biol. Chem.
283: 12546-12554
[Abstract]
[Full Text]
-
Enesa, K., Zakkar, M., Chaudhury, H., Luong, L. A., Rawlinson, L., Mason, J. C., Haskard, D. O., Dean, J. L. E., Evans, P. C.
(2008). NF-{kappa}B Suppression by the Deubiquitinating Enzyme Cezanne: A NOVEL NEGATIVE FEEDBACK LOOP IN PRO-INFLAMMATORY SIGNALING. J. Biol. Chem.
283: 7036-7045
[Abstract]
[Full Text]
-
Reiley, W. W., Jin, W., Lee, A. J., Wright, A., Wu, X., Tewalt, E. F., Leonard, T. O., Norbury, C. C., Fitzpatrick, L., Zhang, M., Sun, S.-C.
(2007). Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responses. JCB
177: i16-i16
[Full Text]